Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. NB398411

Novus Biologicals™ VEGFR1/Flt-1 Recombinant Protein Antigen
SDP

Catalog No. NB398411
Click to view available options
:
100 ul

Description

Recombinant Protein

Specifications

For Use With (Application) Antibody Competition
Formulation PBS and 1M Urea, pH 7.4.
Gene ID (Entrez) 2321
Molecular Weight (g/mol) 31 kDa
Quantity 100 μL
Storage Requirements Store at -20°C. Avoid freeze-thaw cycles.
Gene Alias EC 2.7.10, EC 2.7.10.1, FLT, FLT-1, Fms-like tyrosine kinase 1, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascularpermeability factor receptor), FRT, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, vascular endothelial growth factor receptor 1, Vascular permeability factor receptor, VEGFR1, VEGFR-1
Gene Symbol FLT1
Inhibitor Properties This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-30982. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/mL.
Research Category Angiogenesis, Cancer, Cellular Markers, Endothelial Cell Markers, HIF Target Genes, Hypoxia, Myeloid derived Suppressor Cell, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Protein VEGFR1/Flt-1
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.